ILA – Island Pharmaceuticals Limited
Island Pharmaceuticals is a drug research and repurposing company, focused on developing preventative or therapeutic drugs for viral infections. The Company has a lead program in dengue that was initially developed by Island’s wholly owned subsidiary, Isla Pharmaceuticals, Inc. (a company incorporated in the United States, referred to as Isla US).
Isla US is currently advancing its lead drug candidate “Isla101” towards a Phase 2 clinical trial in dengue infected subjects. Isla101 also has…
